Ozempic Could Be Much less Efficient for Emotional Eaters, Research Suggests

GLP-1 agonists—so-called “wonder medicine” like Ozempic or Wegovy that assist people decrease blood sugar ranges and drop some pounds, amongst different issues—yield vital outcomes for some sufferers, however not all. Folks’s motivations to overeat could play a task on this, in response to a brand new research.

To analyze why some folks don’t profit from GLP-1 agonists as a lot as others, researchers noticed 92 contributors with sort 2 diabetes in Japan throughout their first yr of taking GLP-1 medicine. Their results, printed at present in Frontiers in Medical Diabetes and Healthcare, recommend that individuals who overeat as a consequence of exterior causes—such because the sight or odor of scrumptious meals—had higher possibilities of responding effectively to the medicine in the long run than individuals who overeat for emotional causes.

Who will profit most from GLP-1 medicine?

“Pre-treatment evaluation of consuming habits patterns could assist predict who will profit most from GLP-1 receptor agonist remedy,” Daisuke Yabe, senior writer of the research and a professor of diabetes, endocrinology, and diet at Kyoto College, stated in a Frontiers assertion. “GLP-1 receptor agonists are efficient for people who expertise weight achieve or elevated blood glucose ranges as a consequence of overeating triggered by exterior stimuli. Nevertheless, their effectiveness is much less anticipated in instances the place emotional consuming is the first trigger.”

The workforce revealed this by gathering information on the contributors’ physique weight and composition, weight loss program, and data akin to blood glucose, levels of cholesterol, and relationship with meals at first of the therapy, three months after, and one yr after. They targeted on emotional consuming (consuming in response to damaging feelings), exterior consuming (consuming as a result of the meals seems good), and restrained consuming (controlling one’s weight loss program to drop some pounds). Whereas it might sound contradictory, extreme restrained consuming can really lead to disordered consuming, in response to the researchers.

Over the yr, the contributors skilled a statistically vital lack of physique weight and lowered levels of cholesterol and physique fats share with out altering skeletal muscle mass. Whereas blood glucose ranges ameliorated, the advance wasn’t statistically vital. There have been, nevertheless, some variations relying on consuming behaviors. Three months after the beginning of the therapy, contributors reported extra restrained consuming and fewer exterior or emotional consuming. By the tip of the yr, although, contributors had returned to their authentic restrained and emotional consuming habits.

“One potential rationalization is that emotional consuming is extra strongly influenced by psychological elements which is probably not straight addressed by GLP-1 receptor agonist remedy,” stated Takehiro Kato, second writer of the article and a researcher from Gifu College, “People with distinguished emotional consuming tendencies could require extra behavioral or psychological assist.”

Exterior consuming lessened over the yr of therapy

Contributors reported decreased exterior consuming all through all the yr, and people that claimed excessive ranges of exterior consuming at first of the therapy noticed the best advantages in blood glucose ranges and weight reduction. However, the workforce didn’t determine any affiliation between emotional or restrained consuming scores at first and drug advantages by the 12-month mark.

“Whereas our research suggests a possible affiliation between exterior consuming habits and therapy response to GLP-1 receptor agonists, these findings stay preliminary,” defined Yabe. What’s extra, the workforce’s research was observational, and contributors self-reported info, which means the researchers revealed a possible affiliation, not a causation.

“Additional proof is important earlier than they are often carried out in medical apply. Ought to future large-scale or randomized managed trials validate this relationship, incorporating easy behavioral assessments may turn into a helpful part in optimizing therapy methods,” Yabe concluded.